INSIDER TRADING

Legend Biotech Corp director Peter Salovey makes first open-market buy in 12 months: $183,250

By Insider Stock Trader Newsroom1 min readInsider Stock Trader
Legend Biotech Corp director Peter Salovey makes first open-market buy in 12 months: $183,250

The purchase raises the insider's holding by 36%, the filing shows. Information only, not investment advice.

Insider buying at Legend Biotech Corp: Peter Salovey, a director, added 20,000 shares between Nov 12 and Nov 13 for $183,250, at an average of $9.16 a share, a Form 4 filed on Nov 16 shows.

It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. After the trade, the filing lists 75,096 shares held.

It is the insider's first open-market purchase of LEGN in at least 12 months. The filing came 3 days after the trade.

The numbers below are taken from the Form 4 as filed with the SEC.

The purchase
CompanyLegend Biotech Corp (LEGN)
InsiderPeter Salovey
RoleDirector
TransactionOpen-market purchase (code P)
Shares20,000
Average price$9.16
Value$183,250
Trade datesNov 12 to Nov 13, 2026
Filed with the SECNov 16, 2026, 4:10 PM ET
Shares held after75,096
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

View the Form 4 on SEC.gov

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.